Literature DB >> 2060524

Treatment of acute toxoplasmosis with oral clindamycin.

K V Rolston1.   

Abstract

The combination of pyrimethamine and clindamycin, both administered orally, was evaluated for initial and maintenance therapy of toxoplasmosis in eight AIDS patients who were either allergic to sulfonamides or unresponsive to standard therapy. Symptomatic and neuroradiographic improvement occurred in the majority of patients. The regimen was well tolerated and associated with minimal toxicity, and appeared to be an effective alternative to standard therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060524     DOI: 10.1007/bf01964456

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  4 in total

1.  Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome.

Authors:  F M Gordin; G L Simon; C B Wofsy; J Mills
Journal:  Ann Intern Med       Date:  1984-04       Impact factor: 25.391

2.  Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome.

Authors:  B J Luft; R G Brooks; F K Conley; R E McCabe; J S Remington
Journal:  JAMA       Date:  1984-08-17       Impact factor: 56.272

3.  Clindamycin in a murine model of toxoplasmic encephalitis.

Authors:  J M Hofflin; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

4.  Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients.

Authors:  W D Snider; D M Simpson; S Nielsen; J W Gold; C E Metroka; J B Posner
Journal:  Ann Neurol       Date:  1983-10       Impact factor: 10.422

  4 in total
  3 in total

1.  Effect of clindamycin on intracellular replication, protein synthesis, and infectivity of Toxoplasma gondii.

Authors:  J Blais; C Tardif; S Chamberland
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

2.  Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats.

Authors:  M G Davidson; M R Lappin; J R Rottman; M B Tompkins; R V English; A T Bruce; J Jayawickrama
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

3.  Host Cell Metabolism Contributes to Delayed-Death Kinetics of Apicoplast Inhibitors in Toxoplasma gondii.

Authors:  Katherine Amberg-Johnson; Ellen Yeh
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.